Cerebras Systems CBRS Stock Slides As Wall Street Turns Bullish On AI Deals

Cerebras Systems Inc. stocks have been trading up by 15.17 percent after upbeat AI chip demand headlines boosted investor optimism.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading CBRS

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Morgan Stanley raised its price target on CBRS, forecasting core revenue more than tripling by 2027 on AI inference demand and massive new data center capacity, despite execution risks.
OpenAI’s new GPT‑15.6 Sol Ultrafast mode runs on Cerebras hardware, delivering up to 750 tokens per second and strong benchmark results, yet the stock still dropped nearly 14% on the news.
Shares of CBRS fell over 12% after a Q2 loss, even though core revenue more than doubled year over year and beat expectations on cloud-driven strength.
A 10‑year CleanCore colocation deal and AMD technical partnership give Cerebras a dedicated AI campus and a disaggregated inference stack using its Wafer‑Scale Engine with AMD Helios systems.
Tiger Global opened a sizable new CBRS position in Q2 2026, signaling hedge fund interest despite volatility.

Quick Financial Overview

CBRS has been trading like a high‑beta AI rocket. Over the past few weeks, Cerebras Systems Inc. has ripped from the high $160s to closes above $250, with multiple wide‑range days showing aggressive two‑sided trading. The recent close near $251.98 caps a powerful rebound from the $169.39 low in late July, a gain of roughly 49% in just a few weeks.

Intraday, CBRS shows tight action around $250–$256, with repeated tests of the mid‑$250s that keep failing. That tells traders there is a clear near‑term supply zone overhead. A break and hold above that band could trigger another leg higher; repeated rejections could set up a sharp pullback.

Fundamentally, Cerebras is still deep in loss‑making mode. Q2 2026 revenue hit $180.11M, but net income was a steep loss of about $450.53M, and EBITDA ran negative at roughly $403.10M. The pretax profit margin near ‑124% and a price‑to‑sales ratio around 139.3 scream “hyper‑growth story, not value play.” CBRS is spending heavily, especially on research and development at $320.15M this quarter, to chase AI scale.

More Breaking News

Yet the balance sheet is strong for now. Cerebras ended the quarter with $6.46B in cash and a hefty $7.92B in cash, equivalents, and short‑term investments. Free cash flow was negative at roughly ‑$476.73M, but the company raised about $6.23B through stock issuance, pushing total cash up by $4.68B quarter over quarter. For traders, that means CBRS has runway to fund its expansion, even as return on assets and equity sit in the red.

Why Traders Are Watching CBRS So Closely

CBRS is the kind of name momentum traders love and fear at the same time. On one side, Cerebras Systems Inc. just landed exactly the kind of validation any AI hardware player dreams of: its chips are powering OpenAI’s GPT‑15.6 Sol Ultrafast mode, pushing up to 750 tokens per second and as much as 14x the speed of standard modes. That system also scored well on the “Humanity’s Last Exam” benchmark, putting Cerebras tech squarely in the top tier of AI inference.

Yet CBRS sold off nearly 14% on that headline. Same story around earnings: Cerebras reported Q2 2026 core revenue that more than doubled year over year and beat market expectations, but the stock still dropped more than 12% after the company posted a sizable loss. This is classic “sell the news” action in a crowded AI trade where expectations run hot and any hint of execution risk brings fast profit‑taking.

Analysts are not flinching. Morgan Stanley reiterated its overweight rating on Cerebras Systems, increased its price target, and now models core revenue more than tripling by 2027. The firm points to booming AI inference demand, large‑scale data center expansion, and new inference deals with AMD and AWS. The catch is execution: Cerebras has over 600MW of capacity to bring online. Scaling that cleanly, on time and on budget, is a big task.

Strategically, CBRS is not trying to fight GPUs; it is trying to ride with them. The AMD partnership is key here. Cerebras is integrating its Wafer‑Scale Engine with AMD Helios rack‑scale GPU systems in a disaggregated AI inference workflow, targeting up to 5x better tokens‑per‑second‑per‑watt versus WSE‑only setups. That hybrid design is slated for Cerebras data centers and Cerebras Cloud in 2H 2026, and another AMD‑aligned inference solution is being promoted as part of AMD’s broader AI push.

Add in a 10‑year colocation deal with CleanCore for a dedicated AI campus in Minnesota, plus a CrowdStrike partnership that embeds Cerebras hardware into Falcon AIDR while using Falcon to secure Cerebras’ own infrastructure, and you get a picture of a company racing to lock in ecosystem, capacity, and flagship customers. The Tiger Global stake, one of its biggest new buys in Q2 2026, reinforces that some big‑name hedge funds are willing to lean into the volatility.

For active traders watching CBRS, this mix of marquee partnerships, huge capex, and violent reactions to every headline is exactly what creates opportunity—if you respect the risk.

Conclusion

Cerebras Systems Inc. sits at the intersection of two powerful forces: the AI build‑out and high‑octane trading psychology. CBRS is printing big losses now, with a pretax margin deep in the red and negative free cash flow, yet it holds a war chest of more than $6B in cash and is plowing money into R&D, data centers, and cloud capacity. That is the typical profile of an early‑stage, high‑growth hardware platform in a land‑grab phase.

On the upside, CBRS has racked up serious credibility. OpenAI is showcasing Cerebras hardware in GPT‑15.6 Sol Ultrafast. AMD is wiring CBRS into its Helios rack‑scale systems and broader AI platform. CrowdStrike is building on Cerebras inference for Falcon AIDR while protecting Cerebras’ own stack. CleanCore is backing a 10‑year campus to house Cerebras AI infrastructure. Morgan Stanley is raising its price target and forecasting a tripling of core revenue by 2027. Tiger Global is stepping in with a large new position. These are not soft signals; they are hard‑earned partnerships and capital commitments.

The flip side is just as real. CBRS has to execute on bringing more than 600MW of capacity online, manage heavy quarterly losses, and navigate a tape that punishes any misstep with double‑digit percentage drops. The daily chart shows a strong trend but also clear resistance in the mid‑$250s, where supply repeatedly steps in.

For traders, the lesson is timeless. As Tim Sykes likes to say, “The market doesn’t reward hope, it rewards preparation—know the story, study the chart, and always be ready to cut losses fast.” In the same spirit of disciplined trading, As Tim Bohen, lead trainer with StocksToTrade says, “A good trade setup checks all the boxes—volume, trend, catalyst. Don’t trade if you’re missing pieces of the puzzle.”. CBRS offers a powerful AI growth story with wild swings to match. Treat it as a trading vehicle, respect the volatility, and let the price action—not the hype—guide your decisions.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!